Amlodipine onset of action
Pro Research Analysisby 
Searched over 200M research papers
Amlodipine Onset of Action: Pharmacokinetics and Clinical Effects
Gradual Onset of Action and Absorption Rate
Amlodipine is known for its slow and gradual onset of action when taken orally. This is mainly due to its intermediate absorption rate, with peak plasma concentrations typically occurring 6 to 8 hours after dosing. As a result, the blood pressure-lowering effect develops gradually over 4 to 8 hours following a single dose, and the return to baseline is also slow, taking up to 24–72 hours after discontinuation. This slow onset is a key feature that distinguishes amlodipine from other calcium channel blockers, which often act more quickly and can cause more pronounced side effects at the start of therapy 134.
Mechanisms Behind the Slow Onset
The slow onset of amlodipine’s action is attributed to its unique physicochemical properties, including a high affinity for cell membranes and slow rates of association and dissociation at receptor sites. These characteristics result in a delayed but sustained pharmacological effect. Studies have shown that amlodipine binds slowly to its target receptors and also dissociates slowly, which explains both the gradual onset and the long duration of its antihypertensive action 238.
Clinical Implications: Tolerability and Side Effects
Because amlodipine’s antihypertensive effect develops slowly, it is associated with a lower incidence of acute vasodilator-related side effects such as headache, flushing, and reflex tachycardia, especially when compared to other drugs like nitrendipine. This slow onset allows the body to adjust more gradually, improving tolerability and potentially enhancing patient compliance 43.
Onset in Vascular and Cellular Studies
In laboratory studies on vascular smooth muscle and human resistance arteries, amlodipine’s inhibitory effects on calcium channels and vessel contraction were also found to be slow and concentration-dependent. The rate of onset could be increased under certain conditions, such as higher levels of depolarization, but overall, the action remained slower than that of other calcium channel blockers 67.
Special Formulations and Onset
Standard oral formulations of amlodipine are designed for a slow onset and long duration. However, research into fast-dissolving tablet formulations aims to provide a quicker onset of action by enhancing the dissolution rate and bioavailability. These formulations have shown promise in releasing most of the drug within 10 minutes, but such rapid-onset products are not the standard clinical choice for hypertension or angina management .
Conclusion
Amlodipine’s onset of action is characteristically slow, with clinical effects on blood pressure developing over several hours after oral administration. This gradual onset is due to its unique pharmacokinetic and receptor-binding properties, resulting in sustained efficacy and improved tolerability compared to faster-acting calcium channel blockers. While new formulations may offer a quicker onset, the standard use of amlodipine relies on its slow, steady action for effective long-term blood pressure control 1234+1 MORE.
Sources and full results
Most relevant research papers on this topic
Amlodipine: a once daily calcium antagonist.
Amlodipine is an effective once daily treatment for hypertension due to its high oral bioavailability, slow onset of action, and mild natriuretic and diuretic properties.
Amlodipine: an overview of its pharmacodynamic and pharmacokinetic properties.
Amlodipine has a unique pharmacokinetic profile, with a slow onset of action and long duration of effect, potentially benefiting patients with slower reflex tachycardia and lower incidence of vasodilator side effects.
Amlodipine compared to nitrendipine in hypertensive patients: the effects on toleration in relationship to the onset of action.
Amlodipine has a slower onset of action but lower incidence of acute side effects compared to nitrendipine, potentially improving patient compliance.
The unique binding properties of amlodipine: a long-acting calcium antagonist.
Amlodipine has unique binding properties, which explain its slow onset of action and slowed recovery on withdrawal compared to other dihydropyridine-based calcium antagonists.
Formulation and evaluation of fast dissolving tablet of Amlodipine Besylate
The best fast dissolving tablet formulation, F8, containing 8%w/w super-disintegrant Crosscrarmilose sodium, Crosspovidone, and Microcrystalline Cellulose, achieves up to 96.50% drug release in 10 minutes.
DOI